Healthcare >> CEO Interviews >> January 9, 2006

Una Ryan – Avant Immunotherapeutics Inc (avan)

TWST: What has gone on over the past year at AVANT that investors should

focus on?

Dr. Ryan: A number of things. I think one of the most important was the

successful commercialization of